Andina Capital Management’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,694
Closed -$204K 112
2026
Q1
$204K Buy
+1,694
New +$196K 0.18% 113
2025
Q1
Sell
-2,369
Closed -$236K 153
2024
Q4
$236K Sell
2,369
-388
-14% -$40K 0.19% 95
2024
Q3
$313K Sell
2,757
-15
-0.5% -$1.78K 0.24% 79
2024
Q2
$343K Buy
+2,772
New +$357K 0.26% 77

Other funds holding MRK

Andina Capital Management's MRK Position: Q2 2026 in Review

Andina Capital Management sold out of Merck (MRK) in Q2 2026, closing a stake of 1,694 shares — an estimated $204K sold.

Andina Capital Management first reported a position in MRK in Q2 2024 and held it in 4 quarters. The position peaked at $343K in Q2 2024. 3,818 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Andina Capital Management reported no remaining Merck position as of Q2 2026 after selling out during the quarter.
  • Andina Capital Management sold 1,694 Merck shares in Q2 2026, an estimated $204K.
  • Andina Capital Management first reported a position in Merck in Q2 2024 and held it in 4 quarters.
  • Andina Capital Management's Merck position peaked at $343K in Q2 2024.
  • 3,818 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Andina Capital Management's 13F filing for Q2 2026, filed 5 Aug 2026.